Radiation Therapy

The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

Ionizing radiation is used for treating nearly half of all cancer patients. Radiotherapy works by damaging the DNA of cancer cells, and cells sustaining so much DNA damage that they cannot sufficiently repair it will soon cease to replicate and die. It's an effective strategy overall, and radiotherapy is a common frontline cancer treatment option.

Getty Images

News | Radiation Therapy | June 01, 2021
Measuring the Effects of Radiotherapy on Cancer May Open Up Avenues for Treatment
June 1, 2021 — Ionizing radiation is used for treating nearly half of all cancer patients. Radiotherapy works by...
read more
Winship Cancer Institute of Emory University’s EMPIRE-1 trial is first-of-its-kind randomized patient outcomes study of amino acid PET imaging in influencing a cancer control endpoint
News | Radiation Therapy | May 25, 2021
Results Published for Axumin (Fluciclovine F 18) PET Imaging Study Demonstrating Improved Patient Outcomes in Patients with Recurrent Prostate Cancer
May 25, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization...
read more
LAP is prioritizing clinical awareness, uptake and application of the automated 3D dose-check functionality now incorporated into its RadCalc QA software
News | Radiation Therapy | May 25, 2021
Automated 3D Dose-volume Verification: Gearing Up for Complex Planning scenarios
May 25, 2021 — Independent verification always has been, and likely always will be, the core value proposition for ...
read more
The experimental drug avasopasem manganese protects healthy tissue while enhancing radiation's capacity to kill cancerous tumor cells by converting superoxide to hydrogen peroxide. Image courtesy of Michael Story, Ph.D.

The experimental drug avasopasem manganese protects healthy tissue while enhancing radiation's capacity to kill cancerous tumor cells by converting superoxide to hydrogen peroxide. Image courtesy of Michael Story, Ph.D.

News | Radiation Therapy | May 21, 2021
Experimental Drug Makes Radiation Therapy More Effective, Less Damaging
May 21, 2021 — An experimental drug that has shown promise in protecting healthy tissue from collateral damage caused...
read more
A new study finds that brachytherapy, a common procedure that delivers radiation directly to cancer cells, may continue safely, potentially without delay or antibiotics, in cervical cancer patients following uterine perforation.

Getty Images

News | Brachytherapy Systems, Women's Healthcare | May 19, 2021
Brachytherapy May Continue Following Uterine Perforation in Cervical Cancer Patients
May 19, 2021 — A new study finds that brachytherapy, a common procedure that delivers radiation directly to cancer...
read more
The drug, known as Avasopasem manganese, is made by Galera Therapeutics. It acts like a natural enzyme called superoxide dismutase and converts superoxide into hydrogen peroxide. Based on its ability to "mop up" damaging superoxide molecules, which are produced by radiation treatment, the drug is currently in clinical trials to test its ability to protect mucosal tissue from the side-effect of radiotherapy.

Getty Images

News | Radiation Therapy | May 19, 2021
Hydrogen Peroxide-producing Drug Boosts Cancer-Killing Effect of Radiotherapy
May 19, 2021 — A small drug molecule that appears to protect normal tissue from the damaging effects of radiation, may...
read more
The Clinic by Cleveland Clinic, a transformative joint venture between Cleveland Clinic and Amwell that aligns world-class clinical expertise with the power of innovative digital health technologies, announced that its virtual second opinion solution, available to health plans, employers and consumers, will now include multidisciplinary case analysis.
News | Radiation Oncology | May 18, 2021
The Clinic by Cleveland Clinic Launches New Multidisciplinary Virtual Second Opinion Program for Brain and Prostate Cancer
May 18, 2021 — The Clinic by Cleveland Clinic, a transformative joint venture between Cleveland Clinic and Amwell that...
read more
A study involving researchers at Karolinska Institutet and Gothenburg University in Sweden has found that low levels of a protein called PDGFRb are associated with particularly good results of radiotherapy in women with early-stage breast cancer.
News | Radiation Therapy | May 11, 2021
New Marker Predicts Benefit of Radiotherapy for Early-stage Breast Cancer
May 11, 2021 —A study involving researchers at Karolinska Institutet and Gothenburg University in Sweden has found that...
read more
News | Radiation Therapy | May 06, 2021
Low Doses of Radiation May Improve Quality of Life for Those with Severe Alzheimer's
May 6, 2021 — Individuals living with severe Alzheimer's disease showed remarkable improvements in behavior and...
read more
The emergence of #therapeutic #radiopharmaceuticals and its adoption in #cancer care provide one more weapon in combating cancer

Getty Images

Feature | Radiation Oncology | May 04, 2021 | By Vinay Shivaprasad
The Rise of Therapeutic Radiopharmaceuticals
The term nuclear medicine is associated with the diagnostic procedures single-photon emission computed tomography (...
read more
#prostatecancer During the first wave of the corona pandemic, 36 percent fewer men were diagnosed with prostate cancer in Sweden than in previous years.

Getty Images

News | Prostate Cancer | April 30, 2021
Decrease in Prostate Cancer Diagnoses Due to Pandemic
April 30, 2021 — During the first wave of the corona pandemic, 36 percent fewer men were diagnosed with prostate cancer...
read more
A phase 1 clinical trial led by investigators at the University of Chicago Medicine testing the effects of stereotactic body radiotherapy for treating multiple metastases has determined that treatments used for single tumors can also be safely used for treating patients with multiple metastases.

Image courtesy of Accuray

News | Stereotactic Body Radiation Therapy (SBRT) | April 23, 2021
Study Finds Stereotactic Body Radiotherapy Safe for Treating Patients with Multiple Metastases
April 23, 2021 — A phase 1 clinical trial led by investigators at the University of Chicago Medicine testing the...
read more
A Norwegian study for the first time reveals benefit of the #PARP inhibitor #Olaparib in patients with early #breastcancer not harboring germline mutations

Getty Images

News | Radiation Therapy | April 22, 2021
New Study Reveals Targeted Therapy Working in Early Breast Cancer
April 22, 2021 — Targeted therapy in early stages of breast cancer can pave the way for a notable higher success rate,...
read more
3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine screenings, when compared with traditional mammography, according to a large study from Lund University in Sweden. The results are published in the journal Radiology.

Getty Images

News | Breast Imaging | April 09, 2021
Fewer Breast Cancer Cases Between Screening Rounds with 3-D Mammography
April 9, 2021 — 3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine...
read more
Varian announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer. Varian and Google Cloud AI embarked on a deployment journey, using Neural Architecture Search (NAS) technology via Google Cloud AI Platform, to create AI models for organ segmentation — a crucial and labor-intensive step in radiation oncology that can be a bottleneck in the cancer treatment clinical workflow.
News | Artificial Intelligence | April 08, 2021
Varian and Google Cloud Collaborate to Aid in the Fight Against Cancer
April 8, 2021 — Varian announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI...
read more
Brain tumors edged out by artificial intelligence: VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.

Brain tumors edged out by artificial intelligence: VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.

News | Artificial Intelligence | April 07, 2021
Vysioneer Receives FDA Clearance on First-Ever Tumor Auto-Contouring Solution for Radiation Therapy
April 7, 2021 — Vysioneer, a leader in artificial intelligence (AI) for cancer care, announced it received the U.S....
read more
The National Comprehensive Cancer Network® (NCCN®) and the American Cancer Society (ACS) are teaming up with leading health organizations across the country to endorse the safe resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.
News | Radiation Therapy | March 31, 2021
ASTRO Survey Finds Pandemic Has Led to More Advanced-stage Cancer Diagnoses
March 31, 2021 — Doctors who oversee cancer clinics say that new patients are arriving for treatment with more advanced...
read more
Boston Scientific Corporation announced positive data from the TARGET study of the TheraSphere Y-90 Glass Microspheres (TheraSphere) – a type of radioembolization comprised of millions of microscopic glass beads containing radioactive yttrium (Y-90) – during a late-breaking clinical trial presentation at the annual scientific meeting for the Society of Interventional Radiology (SIR).
News | Interventional Radiology | March 25, 2021
Late-Breaking Clinical Trial Data for TheraSphere Y-90 Glass Microspheres Demonstrates Improved Survival in Primary Liver Cancer
March 25, 2021 — Boston Scientific Corporation announced positive data from the TARGET study of the TheraSphere Y-90 ...
read more
Sun Nuclear Corporation announced that Australia's Northern Sydney Cancer Centre (NSCC) is now a reference site for the SunCHECK Quality Management Platform.
News | Radiation Therapy | March 25, 2021
Northern Sydney Cancer Centre Partners with Sun Nuclear as Newest SunCHECK Platform Reference Site
March 25, 2021 — Sun Nuclear Corporation announced that Australia's Northern Sydney Cancer Centre (NSCC) is now a...
read more
A new study led by Ivan Martinez—associate professor in the WVU School of Medicine and Cancer Institute—found a link between a family of RNAs, the Y chromosome, and radiation sensitivity in male lung-cancer patients
News | Radiation Therapy | March 23, 2021
Loss of Y chromosome, RNA Tied to Radiation Resistance in Male Lung-cancer Patients
March 23, 2021 — The science behind the COVID-19 vaccine has the potential to do more than prevent cases of COVID-19...
read more
© Copyright Wainscot Media. All Rights Reserved.